7-Day Rally Sends GE HealthCare Technologies Stock Up 14%
GE HealthCare Technologies (GEHC) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 14% return. The company has gained about $4.6 Bil in value over the last 7 days, with its current market capitalization at about $37 Bil. The stock remains 3.3% above its value at the end of 2024. This compares with year-to-date returns of 15.8% for the S&P 500.
GEHC’s recent streak was fueled by its $2.3B Intelerad acquisition, bolstering cloud-AI imaging, and new innovations like Photonova Spectra AI-powered CT. Strong Q3 earnings beating estimates and reaffirmed “Buy” ratings underscored robust growth.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.For quick background, GEHC is a global innovator in medical technology, pharmaceutical diagnostics, and digital solutions, serving over 160 countries with extensive sales, service teams, and manufacturing sites worldwide.
Comparing GEHC Stock Returns With The S&P 500
The following table summarizes the return for GEHC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | GEHC | S&P 500 |
|---|---|---|
| 1D | 0.8% | 0.7% |
| 7D (Current Streak) | 14.2% | 2.1% |
| 1M (21D) | 1.5% | -1.1% |
| 3M (63D) | 9.4% | 4.8% |
| YTD 2025 | 3.3% | 15.8% |
| 2024 | 1.3% | 23.3% |
| 2023 | 24.2% | |
| 2022 | -19.4% |
However, big gains can follow sharp reversals – but how has GEHC behaved after prior drops? See GEHC Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 136 S&P constituents with 3 days or more of consecutive gains and 8 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 20 | 7 |
| 4D | 94 | 0 |
| 5D | 14 | 0 |
| 6D | 3 | 0 |
| 7D or more | 5 | 1 |
| Total >=3 D | 136 | 8 |
Key Financials for GE HealthCare Technologies (GEHC)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $19.6 Bil | $19.7 Bil |
| Operating Income | $2.4 Bil | $2.6 Bil |
| Net Income | $1.6 Bil | $2.0 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $5.0 Bil | $5.1 Bil |
| Operating Income | $654.0 Mil | $653.0 Mil |
| Net Income | $486.0 Mil | $446.0 Mil |
While GEHC stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.